D-0559-2016 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

FDA drug recall D-0559-2016 was initiated by PD-Rx Pharmaceuticals, Inc. on Jul 10, 2015 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Mar 8, 2017). Affected quantity: 9 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 6, 2016
Initiation Date
Jul 10, 2015
Termination Date
Mar 8, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
9 bottles

Product description

Clonidine Hydrochloride Tablets, USP, 0.1 mg, 100-count bottles, Rx only, Packaged by PD-RX Pharmaceuticals, Inc., Oklahoma City, OK 73127, MFG: Mutual Pharm. Co. Inc., Philadelphia, PA 19124, NDC 43063-509-01

Reason for recall

cGMP Deviations

Distribution pattern

Alabama

Code information

Lot# B14D26, Exp 02/16

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0559-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0559-2016. Report a data issue: hello@regdatalab.com.